222 related articles for article (PubMed ID: 29741140)
1. Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.
Bellera CL; Sbaraglini ML; Talevi A
Curr Top Med Chem; 2018; 18(5):369-381. PubMed ID: 29741140
[TBL] [Abstract][Full Text] [Related]
2. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
3. In Silico Drug Repositioning for Chagas Disease.
Bellera CL; Alberca LN; Sbaraglini ML; Talevi A
Curr Med Chem; 2020; 27(5):662-675. PubMed ID: 31622200
[TBL] [Abstract][Full Text] [Related]
4. Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective.
Ferreira LG; Andricopulo AD
Drug Discov Today; 2016 Oct; 21(10):1699-1710. PubMed ID: 27365271
[TBL] [Abstract][Full Text] [Related]
5. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
6. Repurposing strategies for tropical disease drug discovery.
Klug DM; Gelb MH; Pollastri MP
Bioorg Med Chem Lett; 2016 Jun; 26(11):2569-76. PubMed ID: 27080183
[TBL] [Abstract][Full Text] [Related]
7. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
8. Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.
Ioset JR; Chang S
Future Med Chem; 2011 Sep; 3(11):1361-71. PubMed ID: 21879842
[TBL] [Abstract][Full Text] [Related]
9. Fostering innovative product development for neglected tropical diseases through partnerships.
Starr A; Graef KM; Dent J
Pharm Pat Anal; 2016 Sep; 5(6):391-400. PubMed ID: 27813447
[TBL] [Abstract][Full Text] [Related]
10. Infectious diseases. Drug developers finally take aim at a neglected disease.
Leslie M
Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
[No Abstract] [Full Text] [Related]
11. Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.
Tavella TA; Cassiano GC; Costa FTM; Sunnerhagen P; Bilsland E
Adv Protein Chem Struct Biol; 2021; 124():275-309. PubMed ID: 33632468
[TBL] [Abstract][Full Text] [Related]
12. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
Yamada H; Hirabayashi F; Brünger C
Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery and development for neglected diseases: the DNDi model.
Chatelain E; Ioset JR
Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487
[TBL] [Abstract][Full Text] [Related]
14. Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases.
Allarakhia M
Drug Des Devel Ther; 2013; 7():753-66. PubMed ID: 23966771
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
16. In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.
Andrade CH; Neves BJ; Melo-Filho CC; Rodrigues J; Silva DC; Braga RC; Cravo PVL
Curr Med Chem; 2019; 26(23):4355-4379. PubMed ID: 29521204
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of anti-infectives.
Agarwal AK; Fishwick CW
Ann N Y Acad Sci; 2010 Dec; 1213():20-45. PubMed ID: 21175675
[TBL] [Abstract][Full Text] [Related]
20. Donated drugs boost protection against neglected tropical diseases.
Gulland A
BMJ; 2013 Jan; 346():f351. PubMed ID: 23325895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
